全文获取类型
收费全文 | 896篇 |
免费 | 29篇 |
国内免费 | 1篇 |
专业分类
电工技术 | 11篇 |
综合类 | 1篇 |
化学工业 | 123篇 |
金属工艺 | 8篇 |
机械仪表 | 20篇 |
建筑科学 | 22篇 |
矿业工程 | 1篇 |
能源动力 | 14篇 |
轻工业 | 104篇 |
水利工程 | 12篇 |
无线电 | 177篇 |
一般工业技术 | 88篇 |
冶金工业 | 259篇 |
原子能技术 | 6篇 |
自动化技术 | 80篇 |
出版年
2022年 | 7篇 |
2021年 | 10篇 |
2020年 | 6篇 |
2019年 | 6篇 |
2018年 | 11篇 |
2016年 | 19篇 |
2015年 | 25篇 |
2014年 | 13篇 |
2013年 | 27篇 |
2012年 | 34篇 |
2011年 | 31篇 |
2010年 | 16篇 |
2009年 | 35篇 |
2008年 | 26篇 |
2007年 | 42篇 |
2006年 | 26篇 |
2005年 | 37篇 |
2004年 | 25篇 |
2003年 | 15篇 |
2002年 | 16篇 |
2001年 | 17篇 |
2000年 | 13篇 |
1999年 | 25篇 |
1998年 | 77篇 |
1997年 | 43篇 |
1996年 | 32篇 |
1995年 | 24篇 |
1994年 | 20篇 |
1993年 | 31篇 |
1992年 | 18篇 |
1991年 | 11篇 |
1990年 | 13篇 |
1989年 | 8篇 |
1988年 | 15篇 |
1987年 | 15篇 |
1986年 | 9篇 |
1985年 | 10篇 |
1984年 | 7篇 |
1982年 | 9篇 |
1980年 | 9篇 |
1979年 | 4篇 |
1978年 | 5篇 |
1977年 | 16篇 |
1976年 | 20篇 |
1975年 | 3篇 |
1973年 | 3篇 |
1970年 | 6篇 |
1969年 | 5篇 |
1968年 | 6篇 |
1967年 | 5篇 |
排序方式: 共有926条查询结果,搜索用时 15 毫秒
101.
B Dehouck L Fenart MP Dehouck A Pierce G Torpier R Cecchelli 《Canadian Metallurgical Quarterly》1997,138(4):877-889
Lipoprotein transport across the blood-brain barrier (BBB) is of critical importance for the delivery of essential lipids to the brain cells. The occurrence of a low density lipoprotein (LDL) receptor on the BBB has recently been demonstrated. To examine further the function of this receptor, we have shown using an in vitro model of the BBB, that in contrast to acetylated LDL, which does not cross the BBB, LDL is specifically transcytosed across the monolayer. The C7 monoclonal antibody, known to interact with the LDL receptor-binding domain, totally blocked the transcytosis of LDL, suggesting that the transcytosis is mediated by the receptor. Furthermore, we have shown that cholesterol-depleted astrocytes upregulate the expression of the LDL receptor at the BBB. Under these conditions, we observed that the LDL transcytosis parallels the increase in the LDL receptor, indicating once more that the LDL is transcytosed by a receptor-mediated mechanism. The nondegradation of the LDL during the transcytosis indicates that the transcytotic pathway in brain capillary endothelial cells is different from the LDL receptor classical pathway. The switch between a recycling receptor to a transcytotic receptor cannot be explained by a modification of the internalization signals of the cytoplasmic domain of the receptor, since we have shown that LDL receptor messengers in growing brain capillary ECs (recycling LDL receptor) or differentiated cells (transcytotic receptor) are 100% identical, but we cannot exclude posttranslational modifications of the cytoplasmic domain, as demonstrated for the polymeric immunoglobulin receptor. Preliminary studies suggest that caveolae are likely to be involved in the potential transport of LDL from the blood to the brain. 相似文献
102.
S Sacchi HM Kantarjian S O'Brien M Beran C Koller S Pierce S Kornblau E Estey MJ Keating M Talpaz 《Canadian Metallurgical Quarterly》1997,11(10):1610-1616
The aim of this analysis was to evaluate the efficacy of alpha-interferon (alpha-IFN) regimens in late chronic phase (diagnosis >12 months) chronic myelogenous leukemia (CP-CML). Long-term follow-up results were evaluated in 137 patients with Philadelphia chromosome (Ph)-positive late CP-CML. The alpha-IFN programs were sequential studies with human leukocyte alpha-IFN (seven patients), recombinant alpha-IFN alone (15 patients) or with IFN-gamma (29 patients), hydroxyurea (HU) (19 patients), or low-dose cytarabine (Ara-C) (67 patients). Overall, 57% of the patients achieved complete hematological response (CHR), and 7% obtained partial hematological response. Nineteen patients (15% of the 123 evaluable patients) had a cytogenetic response which was major (Ph-positive <35%) in 10 patients (8%). A trend for better responses was observed with shorter disease duration. The median overall survival from start of therapy was 49 months, with an estimated 5-year survival rate of 41%. Some common pretreatment prognostic factors associated with response did not show statistical associations when applied in late CP-CML; however, characteristics such as smaller spleen size, and lower percentages of peripheral blood and marrow blasts and basophils were associated with better survival experience. When patients were subgrouped according to risk, no significant differences in the incidence of cytogenetic response and in survival outcomes were observed among various risk groups. This study confirms that alpha-IFN-based regimens have a modest activity in late CP-CML, and supports the need to develop investigational strategies aimed at improving patient prognosis in this phase. 相似文献
103.
The directional preference of kinesin motors is specified by an element outside of the motor catalytic domain 总被引:1,自引:0,他引:1
Members of the kinesin superfamily share a similar motor catalytic domain yet move either toward the plus end (e.g., conventional kinesin) or the minus end (e.g., Ncd) of microtubules. The structural features that determine the polarity of movement have remained enigmatic. Here, we show that kinesin's catalytic domain (316 residues) in a dimeric construct (560 residues) can be replaced with the catalytic domain of Ncd and that the resultant motor moves in the kinesin direction. We also demonstrate that this chimera does not move processively over many tubulin subunits, which is similar to Ncd but differs from the highly processive motion of conventional kinesin. These findings reveal that the catalytic domain contributes to motor processivity but does not control the polarity of movement. We propose that a region adjacent to the catalytic domain serves as a mechanical transducer that determines directionality. 相似文献
104.
105.
S Sacchi HM Kantarjian TL Smith S O'Brien S Pierce S Kornblau M Beran MJ Keating M Talpaz 《Canadian Metallurgical Quarterly》1998,16(3):882-889
PURPOSE: To determine, in patients with Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML) on interferon alfa (IFNalpha), whether combining pretreatment characteristics and early response profiles would distinguish patients with differential benefits that would allow better decisions on subsequent therapy. PATIENTS AND METHODS: A total of 274 patients treated from 1982 through 1990 with IFNalpha regimens were analyzed. A second group of 137 patients treated with IFNalpha and low-dose cytarabine (ara-C) between 1990 and 1994 was later used to confirm the guidelines derived from the original study group analysis. Patients' pretreatment factors and response to IFNalpha therapy at 3, 6, and 12 months were analyzed in relation to subsequent achievement of major cytogenetic response. After univariate analysis of prognostic factors, a multivariate analysis selected, at 6 months, independent pretreatment factors that added to the response status in predicting subsequent outcome. The results were then applied at the 3- and 12-month periods and confirmed in the subsequent population. RESULTS: Response to IFNalpha therapy at 3, 6, and 12 months was a significant predictor of later major cytogenetic response. The presence of splenomegaly > or = 5 cm below the costal margin (BCM) or thrombocytosis > or = 700 x 10(9)/L pretreatment added significant independent prediction to response. At 6 months, patients with a partial hematologic response (PHR) or resistant disease had a less than 10% chance of achieving a later major cytogenetic response, as were those in complete hematologic response (CHR) and who had pretreatment splenomegaly and thrombocytosis. Applying the model at 3 months showed that only patients with < or = PHR and pretreatment splenomegaly or thrombocytosis at 3 months had such a low major cytogenetic response rate. Finally, at 12 months, patients with CHR still had a 15% to 25% chance of having a major cytogenetic response later if they did not have pretreatment splenomegaly and thrombocytosis. CONCLUSION: This analysis allows better selection of patients with Ph-positive CML on IFNalpha therapy for continuation of IFNalpha versus changing therapy early in the course of CML. For treatment programs that choose to change patients to other investigational therapies (eg, intensive chemotherapy and/or autologous stem-cell transplantation [SCT]), baseline outcome expectations are provided for patients continued on IFNalpha therapy, against which the results of new approaches can be compared. 相似文献
106.
107.
108.
In an attempt to decrease the incidence of driving under the influence of alcohol (DUI), some alcohol-serving establishments have installed blood-alcohol level (BAL) feedback devices. These devices are meant to increase awareness of intoxication and result in the avoidance of DUI. However, studies in the US, Canada, and New Zealand (e.g., J. F. Oates, 1976; J. Calvert-Boyanowsky and E. O. Boyanowsky, 1980; P. M. Hurst and P. G. Wright, 1981) indicate that BAL feedback does not deter intoxicated individuals from DUI. Moreover, there is some evidence that it may increase alcohol consumption. The education of alcohol servers about effective techniques they can use to prevent DUI is suggested as a more effective means of preventing DUI. (PsycINFO Database Record (c) 2010 APA, all rights reserved) 相似文献
109.
110.
Bone marrow from mature goats and sheep was cultured in plasma clots, and three erythropoietin (ESF)-dependent responses-growth (colony formation), differentiation (globin production), and initiation of hemoglobin C (alpha2beta2C) synthesis--were quantitated. ESF concentrations below 0.01 U/ml supported colony growth and adult hemoglobin production in cultures of goat marrow, while maximal hemoglobin C synthesis (70%), as measured between 72 and 96 h in culture, required a 100-fold higher ESF concentration. Sheep marrow was cultured in a medium enriched to enhance growth and to permit complete maturation of colonies. These colonies active in hemoglobin synthesis between 24 and 96 h produced mainly adult hemoglobin, and only between 96 and 120 h did sheep colonies develop which produced mainly hemoglobin C (up to 70%). A similar heterogeneity may exist among goat colonies. Thus, when goat bone marrow was fractionated by unit gravity sedimentation, more hemoglobin C synthesis was observed in colonies derived from cells of intermediate sedimentation velocity than in colonies derived from the most rapidly sedimenting cells. Brief exposure of sheep (in vivo) and goat (in vitro) bone marrow to a high ESF concentration committed precursor cells to the generation of colonies which, even at low ESF concentration, produced hemoglobin C. Committment to hemoglobin phenotype appears to be an early and probably irreversible event in the development of an erythroid cell. 相似文献